Sleep therapy may boost quit rates for tobacco and cannabis users

NCT ID NCT07202351

Recruiting now Symptom relief Sponsor: Centre Hospitalier St Anne Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether screening and treating sleep disorders during tobacco or cannabis cessation therapy helps people stay abstinent longer. 80 participants will either get usual care or extra sleep-focused care. The study follows them for 6 months to see if addressing sleep issues reduces relapse.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: screening and management of sleep disorders (cognitive behavioural therapy, image rehearsal therapy)
What this could lead to: If it works, this could point toward a simple way to improve quit rates for tobacco or cannabis by addressing sleep problems during withdrawal.
What could go wrong: This is a small pilot study with only 80 people, so results may not apply widely. The intervention adds extra steps, and sleep treatment may not directly improve abstinence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive cannabis dependence nicotine dependence sleep disorder sleep-wake disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SLEEP DISORDER

Contacts and locations

Locations

GHU Paris Psychiatrie et Neurosciences
RECRUITING

Paris, Île-de-France Region, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.